Submitted by Anonymous (not verified) on 31 October 2023 - 14:58
Human medicines European public assessment report (EPAR): Benlysta, belimumab, Lupus Erythematosus, Systemic, Date of authorisation: 13/07/2011, Revision: 31, Status: Authorised
Source: